~~<i id='1DA484EAE1'><strike id='1DA484EAE1'><tt id='1DA484EAE1'><pre id='1DA484EAE1'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

knowledge

hotspot

author：Wikipedia 2025-08-26 23:48:32 - browse：327

Blue nerve cell surrounded by red antibodies. -- health coverage from STAT — Adobe

Belgian drugmaker Argenx said Monday that its antibody treatment called Vyvgart significantly delayed the progression of an autoimmune nerve disorder that causes people to lose feeling and muscle strength in the arms and legs.

The positive outcome — a 61% reduction in the risk of relapse compared to a placebo — achieved the main goal of a Phase 3 clinical trial designed to demonstrate Vyvgart’s benefit for patients with chronic inflammatory demyelinating polyneuropathy, or CIDP.

“We hit the bullseye,” said Argenx CEO Tim Van Hauwermeiren.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medical records are filled with copy
Next article： New case study details death in closely watched Alzhiemer's trial

knowledge

focus

knowledge

hotspot

knowledge

DavidSabatini,abiologistwhooncegeneratedNobelPrizebuzz.WikimediaCommonsThe7a.m.AcelaoutofSouthStatio

WSS

Russia says it foiled Ukrainian drone attack on Moscow as Kyiv's counteroffensive grinds on

FAA sets up new process for Hawaii air tour operators to fly at lower altitudes after fatal crashes

Listen: Biotech layoffs, eye drug drama, & gene therapy milestones

The cancer stories no one wants to hear

The a glaring gap in research on serious mental illness and primary care

These geoengineering technologies could help combat the climate crisis, scientists say

knowledge

hotspot

knowledge

Affirmative action in medical school literally saved lives

Late stage cancers on the rise after pandemic delayed screenings

DIEP, the 'gold standard' of breast reconstruction, is under threat

4 killed, 7 hurt in mass shooting at July 4 block party in Louisiana; no arrests made

Cancer drug shortages should be causing more outrage

Australia's humpback populations rebound raising hopes of marine scientists

Sports medicine is finally prioritizing gender equality

Physicians aren't 'burning out.' They're suffering from moral injury

Cancer drug shortages should be causing more outrage

Connecting traumatic brain injury and domestic violence

knowledge

4 killed, 7 hurt in mass shooting at July 4 block party in Louisiana; no arrests made

New case study details death in closely watched Alzhiemer's trial

Doctor appointment wait times are getting worse

Connecting traumatic brain injury and domestic violence

Community addresses injustice for Long Island mothers

Make 'food is medicine' a key part of White House nutrition meeting

focus

knowledge

hotspot

knowledge